Advanced Lipids’ Infat shows strong bone growth potential for infants

c9ebf246-c4b4-4be0-8355-3c121e91a2a7articleimage.jpg

17 Nov 2017 --- Advanced Lipids’ SN-2 infant formula ingredient Infat may have the potential to support healthy bone growth, a study has shown. The study published in Nutrients may be especially interesting for children with special nutritional needs, among others.

Palmitic acid is the most abundant saturated fatty acid in human milk, where it is primarily located in the SN-2 position, Advanced Lipids notes. SN-2 palmitate is a well-established structured fat added to infant formulas. It is already known to offer a range of benefits for babies, including longer sleep duration and reduced crying.

Recently, researchers set out to explore the effect that SN-2 palmitate has on the length and quality of bones in a catch-up growth model. After restricting the diets of two groups of rats, one group was fed with a diet enriched with Infat – Advanced Lipids’ SN-2 palmitate ingredient – and the other with a standard diet.

Weight gain was similar between the two groups and there were no adverse effects from either diet. However, rats in the Infat group scored higher on parameters such as humerus length. Values relating to bone quality also seemed higher in the Infat group, although the difference did not reach statistical significance.

Researchers also analyzed gene expression in the two groups and found that three genes in the liver showed an increase in the Infat group. They say these may be associated with growth and development in the epidermal growth plate.

“Infat is already a well substantiated structured fat for infant formula with multiple clinical studies proving its benefits for infant nutrition,” comments Dr. Sigalit Zchut, Chief Scientist at Advanced Lipids. “However, as an innovative company, Advanced Lipids is testing its effect in other fields as well.”

“This study is exciting because it shows that SN-2 palmitate may have a beneficial effect on the length and quality of bones of mice that were subjected to food restriction, followed by nutrition-induced catch-up growth,” Zchut adds. “Though this is a pre-clinical study, its implications may be important, especially for children with growth disorders and children with special nutritional needs.”

Related Articles

Nutrition & Health News

Research driving demand for OPO in China’s formula market: Advanced Lipids

16 Feb 2018 --- OPO is increasing in popularity in China’s infant formula market, and according to Advanced Lipids, this is down to the growing body of scientific research backing the benefits of this ingredient. Also known as SN-2 palmitate, OPO is a premium quality ingredient that mimics the fatty acid profile of human milk.

Nutrition & Health News

Bridging the fiber gap: Tereos launches website on dietary fiber

13 Feb 2018 --- Consuming an adequate amount of fiber plays an important role in a wide range of health-related issues, by helping to reduce obesity, improve cholesterol and glycemic index levels and contribute to weight management. To educate consumers about dietary fibers, Tereos has launched a new website, which it says makes it easy to understand the company's Actilight fiber ingredient, its benefits and origin. 

Nutrition & Health News

L-Carnitine – "Unquestionable" room for market growth: Lonza

08 Feb 2018 --- From facilitating the recovery process in the sports nutrition sector to improving energy metabolism in healthy aging products, L-Carnitine has proven itself a versatile ingredient with the potential to be applied in myriad applications. “Sports nutrition, weight management, all these areas are still growing. There is no question that there is a lot of room for L-Carnitine’s development. We see a lot of demand coming from Asia and Africa for infant food applications. The other big market is for sure energy drinks,” Marco Gossen, Business Development Manager at Lonza, explains during a NutritionInsight webinar last week, looking at product development and untapped opportunities for L-Carnitine.

Nutrition & Health News

Infant nutrition market becomes a bit more wholesome with gut-friendly organic yogurt launch

01 Feb 2018 --- Premium organic baby food brand Happy Family has launched what it says is the first-ever organic yogurt line with no added sweeteners for babies and toddlers. Designed for infants starting at six months and up to three years old, the Happy Baby and Happy Tot Whole Milk Yogurt line is made with whole milk, vitamin D and probiotics. 

Business News

Nestlé and GSK among potential bidders for Pfizer's consumer health unit, after J&J pulls out of race

29 Jan 2018 --- Johnson & Johnson has withdrawn from the race to buy US drugmaker Pfizer’s consumer health business, leaving Nestlé, GlaxoSmithKline and Reckitt Benckiser among the potential bidders, according to Reuters. Pfizer wants to sell the business, which makes Advil painkillers, Centrum multivitamins and Chapstick lip balm, for no less than US$20 billion, sources have told Reuters. The deadline to submit non-binding offers for the unit is on Thursday.

More Articles
URL : http://www.nutritioninsight.com:80/news/advanced-lipids-infat-shows-strong-bone-growth-potential-for-infants.html